Cargando…

Diagnosis of COVID-19, vitality of emerging technologies and preventive measures

Coronavirus diseases-2019 (COVID-19) is becoming increasing serious and major threat to public health concerns. As a matter of fact, timely testing enhances the life-saving judgments on treatment and isolation of COVID-19 infected individuals at possible earliest stage which ultimately suppresses sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Asif, Muhammad, Xu, Yun, Xiao, Fei, Sun, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103773/
https://www.ncbi.nlm.nih.gov/pubmed/33994842
http://dx.doi.org/10.1016/j.cej.2021.130189
_version_ 1783689365431517184
author Asif, Muhammad
Xu, Yun
Xiao, Fei
Sun, Yimin
author_facet Asif, Muhammad
Xu, Yun
Xiao, Fei
Sun, Yimin
author_sort Asif, Muhammad
collection PubMed
description Coronavirus diseases-2019 (COVID-19) is becoming increasing serious and major threat to public health concerns. As a matter of fact, timely testing enhances the life-saving judgments on treatment and isolation of COVID-19 infected individuals at possible earliest stage which ultimately suppresses spread of infectious diseases. Many government and private research institutes and manufacturing companies are striving to develop reliable tests for prompt quantification of SARS-CoV-2. In this review, we summarize existing diagnostic methods as manual laboratory-based nucleic acid assays for COVID-19 and their limitations. Moreover, vitality of rapid and point of care serological tests together with emerging biosensing technologies has been discussed in details. Point of care tests with characteristics of rapidity, accurateness, portability, low cost and requiring non-specific devices possess great suitability in COVID-19 diagnosis and detection. Besides, this review also sheds light on several preventive measures to track and manage disease spread in current and future outbreaks of diseases.
format Online
Article
Text
id pubmed-8103773
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-81037732021-05-10 Diagnosis of COVID-19, vitality of emerging technologies and preventive measures Asif, Muhammad Xu, Yun Xiao, Fei Sun, Yimin Chem Eng J Article Coronavirus diseases-2019 (COVID-19) is becoming increasing serious and major threat to public health concerns. As a matter of fact, timely testing enhances the life-saving judgments on treatment and isolation of COVID-19 infected individuals at possible earliest stage which ultimately suppresses spread of infectious diseases. Many government and private research institutes and manufacturing companies are striving to develop reliable tests for prompt quantification of SARS-CoV-2. In this review, we summarize existing diagnostic methods as manual laboratory-based nucleic acid assays for COVID-19 and their limitations. Moreover, vitality of rapid and point of care serological tests together with emerging biosensing technologies has been discussed in details. Point of care tests with characteristics of rapidity, accurateness, portability, low cost and requiring non-specific devices possess great suitability in COVID-19 diagnosis and detection. Besides, this review also sheds light on several preventive measures to track and manage disease spread in current and future outbreaks of diseases. Elsevier B.V. 2021-11-01 2021-05-07 /pmc/articles/PMC8103773/ /pubmed/33994842 http://dx.doi.org/10.1016/j.cej.2021.130189 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Asif, Muhammad
Xu, Yun
Xiao, Fei
Sun, Yimin
Diagnosis of COVID-19, vitality of emerging technologies and preventive measures
title Diagnosis of COVID-19, vitality of emerging technologies and preventive measures
title_full Diagnosis of COVID-19, vitality of emerging technologies and preventive measures
title_fullStr Diagnosis of COVID-19, vitality of emerging technologies and preventive measures
title_full_unstemmed Diagnosis of COVID-19, vitality of emerging technologies and preventive measures
title_short Diagnosis of COVID-19, vitality of emerging technologies and preventive measures
title_sort diagnosis of covid-19, vitality of emerging technologies and preventive measures
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103773/
https://www.ncbi.nlm.nih.gov/pubmed/33994842
http://dx.doi.org/10.1016/j.cej.2021.130189
work_keys_str_mv AT asifmuhammad diagnosisofcovid19vitalityofemergingtechnologiesandpreventivemeasures
AT xuyun diagnosisofcovid19vitalityofemergingtechnologiesandpreventivemeasures
AT xiaofei diagnosisofcovid19vitalityofemergingtechnologiesandpreventivemeasures
AT sunyimin diagnosisofcovid19vitalityofemergingtechnologiesandpreventivemeasures